‘Chemo brain’ may have targetable causes

BOSTON – The risk for cognitive decline following cancer treatment varies by both cancer and therapy types, and can range from subtle changes to severe deficits, according to a researcher. Patients...

Field of Interest: Oncology
Type: News Item

Alzheimer’s may be declining in U.S. and Germany

COPENHAGEN – The incidence of Alzheimer’s disease appears to be declining in the United States and may be following a similar positive trend in Germany as well. An analysis of the ongoing Framingham...

Field of Interest: Geriatrics
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.